Skip to main content
QTI
NASDAQ Industrial Applications And Services

QT Imaging Cuts FY26 Revenue Guidance to ~$34M Despite 75% Q3 Growth

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.001
Mkt Cap
$33.079M
52W Low
$2.01
52W High
$7.6
52W Position info
0.4% below low
Off High info
74% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

QTI is trading near its 52-week low of $2.01 (0.4% below the low).

Summary

QT Imaging grew Q3 revenue 75% to $7.3 million but cut 2026 guidance to about $34 million from $39 million on Middle East shipping disruptions, while securing a Medicare outpatient payment pathway effective January 1, 2027.


Key Events · Earnings and Guidance · QTI

  • Q3 Revenue Up 75% to $7.3M

    Third-quarter revenue rose to $7.3 million from $4.2 million a year ago on 15 Breast Acoustic CT scanner sales versus nine; nine-month revenue reached $21.3 million with 43 scanners sold versus 23.

  • FY26 Guidance Cut to ~$34M

    Full-year 2026 revenue guidance was lowered to approximately $34 million from approximately $39 million because scanner shipments to Saudi Arabia and UAE distribution partners cannot be completed amid armed conflict and the effective closure of the Strait of Hormuz; U.S. shipment plans are unchanged.

  • Medicare Outpatient Payment Secured

    CMS reversed its earlier proposed nonpayment decision on November 4, 2026, assigning CPT Category III code 1079T to APC 5522 with payment status indicator S, establishing Medicare hospital outpatient payment for eligible diagnostic QTscan exams effective January 1, 2027.

  • Cash Falls to $8.4M

    Cash, cash equivalents and restricted cash totaled $8.4 million at September 30, 2026, down from $11.0 million at June 30, 2026, against $11.4 million of long-term debt and a $14.8 million nine-month net loss.


Analysis · QTI · Industrial Applications And Services

The growth is real: Q3 revenue rose 75% to $7.3 million on 15 scanner sales, and nine-month revenue hit $21.3 million, roughly double last year. But full-year guidance was cut to approximately $34 million from approximately $39 million, because scanners cannot be shipped to Saudi Arabia and the UAE while the Strait of Hormuz is effectively closed to commercial traffic. Against that, CMS reversed its earlier proposed nonpayment decision on November 4, 2026 and set a Medicare hospital outpatient payment pathway for diagnostic QTscan exams starting January 1, 2027, removing a major reimbursement uncertainty for U.S. hospital sales. The balance sheet is the pressure point: cash and restricted cash fell to $8.4 million from $11.0 million at June 30, while long-term debt sits at $11.4 million and the nine-month net loss was $14.8 million — so the $100 million shelf filed in March 2026 remains the likely funding route if U.S. shipments do not accelerate.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, QTI was trading at $2.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.1M. The 52-week trading range was $2.01 to $7.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QTI - Latest Insights

QTI
Nov 10, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $2.25 info
Change: +$0.2489 (+12%) info
Market Cap: $33.079M info
QTI
Nov 10, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $2.26
Real-time Price: $2.25 info
Change: -$0.0100 (-0.44%) info
Market Cap: $33.079M info
QTI
Aug 18, 2026, 8:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.75
Real-time Price: $2.25 info
Change: -$0.500 (-18%) info
Market Cap: $33.079M info
QTI
Aug 12, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.03
Real-time Price: $2.25 info
Change: -$0.780 (-26%) info
Market Cap: $33.079M info
QTI
Aug 12, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.88
Real-time Price: $2.25 info
Change: -$0.630 (-22%) info
Market Cap: $33.079M info